
"I am very hopeful given our enterprise, given the number of vaccines India is developing and the capacity available, hopefully in my own personal read, by quarter 3, we may actually have a situation where supply will meet up the demand or even outstrip," AstraZeneca Pharma India Country President and MD Gagan Singh said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MxALHi
via
IFTTT
0 comments:
Post a Comment